- Home
- ABR vs NVCR Comparison
ABR vs NVCR Comparison
Compare ABR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABR
- NVCR
- Stock Information
- Founded
- ABR 2003
- NVCR 2000
- Country
- ABR United States
- NVCR Switzerland
- Employees
- ABR N/A
- NVCR N/A
- Industry
- ABR Real Estate Investment Trusts
- NVCR Medical/Dental Instruments
- Sector
- ABR Real Estate
- NVCR Health Care
- Exchange
- ABR Nasdaq
- NVCR Nasdaq
- Market Cap
- ABR 1.9B
- NVCR 1.9B
- IPO Year
- ABR 2004
- NVCR 2015
- Fundamental
- Price
- ABR $11.00
- NVCR $17.71
- Analyst Decision
- ABR Hold
- NVCR Buy
- Analyst Count
- ABR 5
- NVCR 6
- Target Price
- ABR $12.13
- NVCR $32.83
- AVG Volume (30 Days)
- ABR 2.9M
- NVCR 1.6M
- Earning Date
- ABR 08-01-2025
- NVCR 07-24-2025
- Dividend Yield
- ABR 11.01%
- NVCR N/A
- EPS Growth
- ABR N/A
- NVCR N/A
- EPS
- ABR 1.03
- NVCR N/A
- Revenue
- ABR $612,893,000.00
- NVCR $621,711,000.00
- Revenue This Year
- ABR N/A
- NVCR $5.56
- Revenue Next Year
- ABR $8.40
- NVCR $9.19
- P/E Ratio
- ABR $10.63
- NVCR N/A
- Revenue Growth
- ABR N/A
- NVCR 18.27
- 52 Week Low
- ABR $8.43
- NVCR $14.17
- 52 Week High
- ABR $15.94
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- ABR 63.23
- NVCR 51.32
- Support Level
- ABR $10.35
- NVCR $17.53
- Resistance Level
- ABR $11.18
- NVCR $18.70
- Average True Range (ATR)
- ABR 0.30
- NVCR 0.72
- MACD
- ABR 0.10
- NVCR 0.09
- Stochastic Oscillator
- ABR 91.45
- NVCR 60.56
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.